{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_isotretinoin",
          "name": "Isotretinoin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_nicotinic_acid",
          "name": "Nicotinic acid"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_thiazide_diuretics",
          "name": "Thiazide diuretics"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_beta_blockers",
          "name": "Beta-blockers"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_estrogens",
          "name": "Estrogens"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_tamoxifen",
          "name": "Tamoxifen"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_dronedarone",
          "name": "Dronedarone"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_glucocorticoids",
          "name": "Glucocorticoids"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sitagliptin",
          "name": "Sitagliptin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_isotretinoin",
          "type": "Target",
          "label": "Off-target effects of Isotretinoin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_isotretinoin",
          "type": "Pathway",
          "label": "Risk pathway for hypertriglyceridemia",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_isotretinoin",
          "type": "Phenotype",
          "label": "Adverse effects in hypertriglyceridemia",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_isotretinoin",
          "target": "n_ot_isotretinoin",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知对脂质代谢有负面影响"
        },
        {
          "source": "n_ot_isotretinoin",
          "target": "n_rp_isotretinoin",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "诱发严重高三酰甘油血症的机制链"
        },
        {
          "source": "n_rp_isotretinoin",
          "target": "n_adv_isotretinoin",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_isotretinoin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "若此风险成立，将抵消潜在治疗益处"
        }
      ],
      "set_weights": [],
      "conflict_hotspots": [
        {
          "topic": "contraindication_for_hypertriglyceridemia",
          "pro_nodes": [
            "drug_isotretinoin"
          ],
          "con_nodes": [
            "n_adv_isotretinoin"
          ],
          "note": "Isotretinoin 对高三酰甘油血症的危险性与疗效辩证关系"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "Isotretinoin已知对脂质水平有显著影响，可能加重病情",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "严重高三酰甘油血症情况下使用临床证据不足",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "Isotretinoin对高三酰甘油血症的影响是否被充分验证",
      "疾病状态下靶组织反应是否与预期一致"
    ],
    "falsification_tests": [
      "若存在研究表明Isotretinoin对高三酰甘油血症影响轻微，则需重新审视",
      "评估是否有实证支持Isotretinoin在类似患者中的应用"
    ],
    "next_focus_for_pi": [
      "要求Proponent提供反驳证据或机制论据",
      "对冲突热点进行权重重估"
    ]
  }
}